# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 89: Amendment to regulation 198

Extent: E+W+S+N.I.

In regulation 198(2) (post-authorisation safety studies: general provisions)—
(a) in sub-paragraph (a) for “marketing authorisation” substitute “UKMA(UK)(Category 2), UKMA(UK)(NI)”;
(b) in sub-paragraph (b) for “marketing authorisation” substitute “UKMA(UK)(Category 1), a UKMA(GB)”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/89 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-89
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.